2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on HER2+ Curative Setting BC: Pertuzumab to SoC Trastuzumab vs. Utilizing T-DM1 for Pts w/ Residual Disease vs. Extending Adjuvant Tx With 1 yr of Neratinib?

0 views
July 16, 2020
Comments 1
Login to view comments. Click here to Login